Murdoch-based regenerative medicine company Orthocell has posted its third consecutive quarter of record revenue, as it gears up for a final approval from the US FDA for its Remplir nerve product.
Our board moves wrap includes Andrew Haythorpe, Gavin Ball, Nicholas Revell, Ravi Thadhani, Arnaud Breuillac, Sarah Ryan, Christopher Haynes, Peter Huljich, Richard Monti, and Jerry Monzu.
